| Ilya Rachman |
Ilya Rachman is the founder of Immix Biopharma, Inc., where he holds the title of Chairman & Chief Executive Officer since 2012. He is also the founder of Nexcella, Inc., where he currently serves as the Executive Chairman. Dr. Rachman has an MBA from the University of California, Los Angeles, and has completed graduate and doctorate degrees from the University of Illinois. He also holds an undergraduate degree from the University of Iowa. |
| Gabriel A. Morris |
Gabriel A. Morris is currently the Chief Financial Officer & Director at Immix Biopharma, Inc. and the Managing Partner at Alwaysraise LLC. He is also the President of Nexcella, Inc. Previously, he served as the Chief Operating Officer at Campbell & Co. LP and as the Chief Financial Officer at ZAP Surgical Systems, Inc. from 2019 to 2020. Mr. Morris obtained his undergraduate degree from The Trustees of Columbia University in The City of New York. |
| Graham Ross |
Graham Ross is currently the Chief Medical Officer & Head-Clinical Development at Immix Biopharma, Inc. He previously worked as the Senior Director-Medical Science at AstraZeneca PLC from 2015 to 2017 and as the Director-Clinical Development at GSK Plc from 1995 to 2006. |
| Jane Melissa Buchan |
Jane Melissa Buchan founded PAAMCO Prisma LLC in 2000, where she worked as Chief Executive Officer & Managing Director from 2000 to 2018. Dr. Buchan also currently works at Martlet Asset Management LLC, as Chief Executive Officer, AGF Management Ltd., as Independent Director from 2017, Immix Biopharma, Inc., as Independent Director from 2021, The Reed Institute, as Trustee, University of California, Irvine Foundation, as Trustee, and Standards Board For Alternative Investments Ltd., as Trustee. Dr. Buchan also formerly worked at PAAMCO Prisma Europe LLP, as Chief Executive Officer from 2003 to 2013, Paamco Prisma Holdings LLC, as Co-Chief Executive Officer from 2017 to 2018, Chartered Alternative Investment Analyst Association, as Chairman from 2012 to 2018, Collins Associates, Inc., as Director-Quantitative Analysis, Girls Who Invest, Inc., as Director, Globe Life, Inc., as Independent Director from 2005 to 2024, Dartmouth College, as Assistant Professor, and Tuck School of Business at Dartmouth, as Assistant Professor-Finance. Dr. Buchan received her graduate degree and doctorate degree from Harvard University and undergraduate degree from Yale University. |
| Jason C. Hsu |
Jason C. Hsu was the founder of Research Affiliates LLC, founded in 2002, where he held the title of Senior Advisor. He is also the founder of Rayliant Global Advisors Ltd., founded in 2012, where he currently holds the title of Chairman & Chief Investment Officer. Currently, Dr. Hsu holds several positions. Since 2016, he has been the Chairman & Chief Investment Officer at Rayliant Asset Management Ltd. Since 2013, he has been an Independent Director at Immix Biopharma, Inc. Since 2008, he has been a Finance Professor at the University of California, Los Angeles. He is also the Chief Investment Officer at Rayliant Investment Research. Starting in 2023, he will be the Chief Economist at East West Bank. In the past, Dr. Hsu worked as a Consultant at Farmers Insurance Group, Inc. (P&C) and as a Principal at The Far Eastern Group. From 2004 to 2007, he was a Professor at the University of California, Irvine. He also worked as a Principal at Shanghai University of Finance & Economics and as a Principal at Oriental Securities Corp. from 1998 to 1999. Dr. Hsu's education includes a graduate degree from Stanford University in 1997, a doctorate degree from the University of California, Los Angeles in 2003, and an undergraduate degree from the California Institute of Technology in 1996. |
| Magda Marquet |
Magda Marquet is the founder of AltheaDx, Inc. (founded in 2009), Ajinomoto Althea, Inc. (founded in 1998), and ALMA Life Sciences LLC (founded in 2013). She held the title of Chairman at Ajinomoto Althea, Inc. from 2009 to 2019. Currently, Dr. Marquet is the Chairman of MatriSys Bioscience, Inc. (since 2018), Chairman of Micronoma, Inc., Independent Director at AnaptysBio, Inc. (since 2021), and Director at HUYA Bioscience International LLC, Independa, Inc., Arcturus Therapeutics, Inc., BIOCOM, UCSD Athena, Economic Development Corp., CONNECT, Voices for Children, Inc., San Diego Athena, SENTÉ, Inc. (California), Kyoto Symposium Organization, Portable Genomics, Inc., Arcturus Therapeutics Ltd. (since 2018), Phoenix Molecular Designs Ltd. (since 2019), Alume Biosciences, Inc. (since 2020), Immix Biopharma, Inc. (since 2021), Arcturus Therapeutics Holdings, Inc. (since 2018), TransCode Therapeutics, Inc. (since 2021), and ProciseDx LLC (since 2020). Dr. Marquet previously worked at Vical, Inc. from 1992 to 1998 as an Executive Director-Pharmaceutical Development, at San Diego Regional Economic Development Corp. as a Director & Trustee, at Pelican Inc. from 2019 to 2020 as an Independent Director, and at Transgene SA from 1983 to 1986 as a Manager. She obtained undergraduate and doctorate degrees from Université Fédérale Toulouse Midi-Pyrénées. |
| Carey J. Ng |
Carey J. Ng is currently the Managing Director at Mesa Verde Ventures LLC since 2013. He is also a Director at Satiogen Pharmaceuticals, Inc., Elysium Therapeutics, Inc., Immix Biopharma, Inc., Paradigm Diagnostics, Inc., and MatriSys Bioscience, Inc. Additionally, he previously worked as a Director at Biscayne Neurotherapeutics, Inc. Dr. Ng holds a doctorate degree from the University of California, Los Angeles, which he obtained in 2004. He also has an MBA from the University of California, conferred in 2008. |
| Helen C. Adams |
Helen C. Adams is currently an Independent Director at Immix Biopharma, Inc. She previously held positions as Chairman at San Diego Athena, Independent Director at Genasys, Inc., Director at Turtle Beach Corp., Director at Young Womens Christian Association USA, Director at Corporate Directors Forum, Director at The Chairmen's RoundTable, Director at American Wind Energy Association, Director at Senior Community Centers, Director at Make-A-Wish Foundation of San Diego, Inc., Director at San Marcos Foundation, Independent Director at Prometheus Biosciences, Inc., Director at Athena Foundation, and Partner at Deloitte & Touche LLP. She also served as Managing Partner-San Diego Chapter at Haskell & White LLP and Board Vice President at Children & Families of Iowa. Ms. Adams obtained her undergraduate degree from San Diego State University. |
| Yekaterina Chudnovsky |
Yekaterina Chudnovsky is currently the Chairman at Gi Research Foundation, Director at Elicio Therapeutics, Inc. (United States), Director at xCures, Inc., Independent Director at Immix Biopharma, Inc., Independent Director at Elicio Therapeutics, Inc., and Director at Gkcc LLC. She has an undergraduate degree from Northwestern University and a graduate degree from DePaul University. |
